Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2014 (2014), Article ID 986525, 6 pages
http://dx.doi.org/10.1155/2014/986525
Research Article

The Serum S100B Level as a Biomarker of Enteroglial Activation in Patients with Ulcerative Colitis

1Department of Neurology, Medical School, Bozok University, 66200 Yozgat, Turkey
2Department of Gastroenterology, Medical School, Bozok University, 66200 Yozgat, Turkey
3Department of Medical Biology, Medical School, Bozok University, 66200 Yozgat, Turkey
4Department of Internal Medicine, Medical School, Bozok University, 66200 Yozgat, Turkey
5Department of Gastroenterology, Medical School, Erciyes University, 38039 Kayseri, Turkey
6Department of Internal Medicine, Medical School, Erciyes University, 38039 Kayseri, Turkey
7Department of Pathology, Medical School, Erciyes University, 38039 Kayseri, Turkey
8Department of Infectious Diseases and Microbiology, Medical School, Bozok University, 66200 Yozgat, Turkey

Received 23 December 2013; Revised 6 February 2014; Accepted 6 March 2014; Published 30 March 2014

Academic Editor: Jonathan Steven Alexander

Copyright © 2014 Asuman Celikbilek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Cirillo, G. Sarnelli, G. Esposito et al., “Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein,” Neurogastroenterology and Motility, vol. 21, no. 11, article e112, p. 1209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Rühl, Y. Nasser, and K. A. Sharkey, “Enteric glia,” Neurogastroenterology and Motility, vol. 16, no. 1, pp. 44–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. G. Bush, T. C. Savidge, T. C. Freeman et al., “Fulminant jejuno-ileitis following ablation of enteric gila in adult transgenic mice,” Cell, vol. 93, no. 2, pp. 189–201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Turco, G. Sarnelli, C. Cirillo et al., “Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells,” Gut, vol. 63, no. 1, pp. 105–115, 2013. View at Google Scholar
  5. C. Cirillo, G. Sarnelli, F. Turco et al., “Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production,” Neurogastroenterology and Motility, vol. 23, no. 9, pp. e372–e382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Kubes and D. M. McCafferty, “Nitric oxide and intestinal inflammation,” The American Journal of Medicine, vol. 109, no. 2, pp. 150–158, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Cornet, T. C. Savidge, J. Cabarrocas et al., “Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 13306–13311, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Geboes and S. Collins, “Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis,” Neurogastroenterology and Motility, vol. 10, no. 3, pp. 189–202, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Cabarrocas, T. C. Savidge, and R. S. Liblau, “Role of enteric glial cells in inflammatory bowel disease,” Glia, vol. 41, no. 1, pp. 81–93, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Esposito, C. Cirillo, G. Sarnelli et al., “Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease,” Gastroenterology, vol. 133, no. 3, pp. 918–925, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. E. Vos, B. Jacobs, T. M. J. C. Andriessen et al., “GFAP and S100B are biomarkers of traumatic brain injury: An observational cohort study,” Neurology, vol. 75, no. 20, pp. 1786–1793, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Herrmann, P. Vos, M. T. Wunderlich, C. H. M. M. de Bruijn, and K. J. B. Lamers, “Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein,” Stroke, vol. 31, no. 11, pp. 2670–2677, 2000. View at Google Scholar · View at Scopus
  13. E. F. Stange, S. P. L. Travis, S. Vermeire et al., “European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis,” Journal of Crohn's and Colitis, vol. 2, no. 1, pp. 1–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Lichtiger, D. H. Present, A. Kornbluth et al., “Cyclosporine in severe ulcerative colitis refractory to steroid therapy,” The New England Journal of Medicine, vol. 330, no. 26, pp. 1841–1845, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. G. D'Haens, W. J. Sandborn, B. G. Feagan et al., “A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis,” Gastroenterology, vol. 132, no. 2, pp. 763–786, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Singleton, A. G. Smith, and M. B. Bromberg, “Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy,” Diabetes Care, vol. 24, no. 8, pp. 1448–1453, 2001. View at Google Scholar · View at Scopus
  17. A. Rühl, “Glial cells in the gut,” Neurogastroenterology and Motility, vol. 17, no. 6, pp. 777–790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Cirillo, G. Sarnelli, G. Esposito, F. Turco, L. Steardo, and R. Cuomo, “S100B protein in the gut: the evidence for enteroglialsustained intestinal inflammation,” World Journal of Gastroenterology, vol. 17, no. 10, pp. 1261–1266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. F. Eng, R. S. Ghirnikar, and Y. L. Lee, “Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000),” Neurochemical Research, vol. 25, no. 9-10, pp. 1439–1451, 2000. View at Google Scholar · View at Scopus
  20. G. B. T. Von Boyen, M. Steinkamp, M. Reinshagen, K.-H. Schäfer, G. Adler, and J. Kirsch, “Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia,” Gut, vol. 53, no. 2, pp. 222–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. R. E. Anderson, L. O. Hansson, O. Nilsson, J. Liska, G. Settergren, and J. Vaage, “Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources,” Annals of Thoracic Surgery, vol. 71, no. 5, pp. 1512–1517, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Michetti, V. Corvino, M. C. Geloso et al., “The S100B protein in biological fluids: more than a lifelong biomarker of brain distress,” Journal of Neurochemistry, vol. 120, no. 5, pp. 644–659, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Donato, G. Sorci, F. Riuzzi et al., “S100B's double life: intracellular regulator and extracellular signal,” Biochimica et Biophysica Acta, vol. 1793, no. 6, pp. 1008–1022, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. W. S. Griffin, L. C. Stanley, C. Ling et al., “Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 19, pp. 7611–7615, 1989. View at Google Scholar · View at Scopus
  25. S. T. Leach, Z. Yang, I. Messina et al., “Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease,” Scandinavian Journal of Gastroenterology, vol. 42, no. 11, pp. 1321–1331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Donato, “RAGE: a single receptor for several ligands and different cellular responses: The case of certain S100 proteins,” Current Molecular Medicine, vol. 7, no. 8, pp. 711–724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. X. Koh and J. K. Lee, “S100B as a marker for brain damage and blood-brain barrier disruption following exercise,” Sports Medicine, vol. 44, no. 3, pp. 369–385, 2014. View at Google Scholar
  28. H. Bartosik-Psujek, M. Psujek, J. Jaworski, and Z. Stelmasiak, “Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone,” Acta Neurologica Scandinavica, vol. 123, no. 4, pp. 252–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Nandi, B. Saud, J. M. Zinkievich, D. T. Palma, and R. A. Levine, “5-Aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats,” Digestive Diseases and Sciences, vol. 53, no. 1, pp. 123–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Gajalakshmi, M. K. Priya, T. Pradeep et al., “Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium,” Toxicology and Applied Pharmacology, vol. 269, no. 2, pp. 121–131, 2013. View at Google Scholar
  31. J. Steiner, K. Schiltz, M. Walter et al., “S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research,” Psychoneuroendocrinology, vol. 35, no. 2, pp. 321–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Gross, J. J. H. van der Heide, W. J. van Son et al., “Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients,” Medical Science Monitor, vol. 16, no. 7, pp. 318–324, 2010. View at Google Scholar · View at Scopus
  33. K. O'Connell, J. Thakore, and K. K. Dev, “Levels of S100B are raised in female patients with schizophrenia,” BMC Psychiatry, vol. 13, article 146, 2013. View at Google Scholar
  34. N. Pham, V. Fazio, L. Cucullo et al., “Extracranial sources of S100B do not affect serum levels,” PLoS ONE, vol. 5, no. 9, Article ID e12691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ehrlich, H. Salbach-Andrae, D. Weiss et al., “S100B in underweight and weight-recovered patients with anorexia nervosa,” Psychoneuroendocrinology, vol. 33, no. 6, pp. 782–788, 2008. View at Publisher · View at Google Scholar · View at Scopus